The LATAM Media Report
SEE OTHER BRANDS

Your media and advertising news from Latin America

The LATAM Media Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.

Press releases published on April 2, 2025

Pest Busterzz Launches Comprehensive Termite Control Services in South Florida

Pest Busterzz Launches Comprehensive Termite Control Services in South Florida

Tamarac, FL, April 02, 2025 (GLOBE NEWSWIRE) -- Pest Busterzz, a proud family-owned organic pest control company dedicated to offering eco-friendly and sustainable pest control solutions, is happy to announce the launch of its comprehensive termite control …

Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology

Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology

WAYNE, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from …

Odysight.ai to participate at MRO Americas 2025 - International trade fair in the Aerospace Industry

Odysight.ai to participate at MRO Americas 2025 - International trade fair in the Aerospace Industry

Omer, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (Nasdaq: ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), today announced its participation in MRO Americas 2025, which will …

Fast Track to AV1 with Beamr: High-Quality at a Fraction of the Cost

Fast Track to AV1 with Beamr: High-Quality at a Fraction of the Cost

Beamr will showcase its high-performance AV1 solutions, accelerated by NVIDIA GPUs, and with simple, competitive pricing, at the 2025 NAB Show in Las Vegas HERZLIYA, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in …

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and …

Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System

Aurora Spine Announces Publication of Biomechanical Study Demonstrating Superiority of SiLO TFX™ Sacroiliac Fusion System

CARLSBAD, California, April 02, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced …

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer …

American Tungsten Corp. Joins The Critical Mineral Institute

American Tungsten Corp. Joins The Critical Mineral Institute

Vancouver, BC, April 02, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that it has become a member of the Critical Minerals Institute (the “CMI”). The CMI …

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners

US …

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners

US …

Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York

Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (‘Marex’), the diversified global financial services platform, provides a Q1 trading update at its Investor Day, being held today at the Nasdaq Marketsite in New York City. Marex …

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it will demonstrate its multimodal vision transformer (ViT) at ISC West 2025 in Las Vegas, April 2-4. Deployed on an …

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment First subjects dosed in double-blind, placebo-controlled trial assessing AT-7687’s safety, tolerability, …

Employee Trust Fuels Financial Success at the 100 Best Companies to Work For in 2025

Employee Trust Fuels Financial Success at the 100 Best Companies to Work For in 2025

Oakland, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Can employee trust be measured in dollars and cents? The 2025 Fortune 100 Best Companies to Work For® have proven that the answer is a resounding yes. On average, the 100 Best Companies earn 8.5 times …

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of …

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

LONDON, April 02, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will …

Green Thumb Industries to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025

Green Thumb Industries to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025

CHICAGO and VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it …

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

NEWTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer …

Mekanism Merges with Camp Jefferson and Jungle to Form Mekanism Canada

Mekanism Merges with Camp Jefferson and Jungle to Form Mekanism Canada

NEW YORK and TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- Mekanism, the agency bringing Soul …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service